Christina Kruuse

Medicine & Life Sciences

1. Stroke 100%
2. Migraine Disorders 36%
3. Sildenafil Citrate 35%
4. Headache 34%
5. Atrial Fibrillation 30%
6. Cerebral Arteries 29%
7. Cerebrovascular Circulation 27%
8. Transient Ischemic Attack 27%
9. Phosphodiesterase 5 Inhibitors 20%
10. Middle Cerebral Artery 20%
11. Type 5 Cyclic Nucleotide Phosphodiesterases 19%
12. Phosphoric Diester Hydrolases 19%
13. Healthy Volunteers 18%
14. Placebos 17%
15. Lacunar Stroke 17%
16. Systematic Reviews 17%
17. Cilostazol 17%
18. Migraine with Aura 15%
19. Regional Blood Flow 14%
20. Duchenne Muscular Dystrophy 14%
21. Denmark 14%
22. Cerebral Hemorrhage 13%
23. Dipyridamole 12%
24. Randomized Controlled Trials 12%
25. Thoracic Surgery 12%
26. Nitric Oxide Synthase Type I 11%
27. Migraine without Aura 11%
28. Cyclic GMP 11%
29. Phosphodiesterase 3 Inhibitors 11%
30. Atrial Appendage 11%
31. Nitroglycerin 11%
32. Exercise 10%
33. Trigeminal Ganglion 9%
34. Hemodynamics 9%
35. High-Intensity Interval Training 9%
36. Anticoagulants 9%
37. Calcitonin Gene-Related Peptide 9%
38. Tadalafil 9%
39. Dilatation 9%
40. Blood Vessels 8%
41. Arteries 8%
42. Cyclic Nucleotides 8%
43. Blood Flow Velocity 8%
44. Sex Characteristics 8%
45. Nitric Oxide 8%
46. Cerebrovascular Disorders 7%
47. Temporal Arteries 7%
48. Epilepsy 7%
49. Blood Pressure 7%
50. Therapeutics 7%